Alnylam (ALNY) PT Cut to $137 at Needham & Company; Long-Term Investors Should Buy Weakness
Go back to Alnylam (ALNY) PT Cut to $137 at Needham & Company; Long-Term Investors Should Buy Weakness| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 145.16 -0.16 (0.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $145.32 | 52 Week High | $109.10 | |||
| Open | $145.00 | 52 Week Low | $31.38 | |||
| Day High | $146.47 | P/E | N/A | |||
| Day Low | $144.23 | EPS | $-1.45 | |||
| Volume | 398,914 | |||||
